SHERMAN DIALYSIS LLC SOS Verified
3291 N BUFFALO DR BLDG A SUITE 150, LAS VEGAS, NV 89129
NPI Number
1881961977
Practice location · View on Google Maps
SOS Verification: Verified
Entity Name: SHERMAN DIALYSIS, LLC
Entity Number: E0497562009-8
Entity Type: Foreign Limited-Liability Company
Entity Status: Active
Formation Date: 2009-09-14
Status Changed: 2010-11-16
Name Match: 95%
Registered Agent
Name: CORPORATION SERVICE COMPANY*
Type: Commercial Registered Agent
Address: 112 NORTH CURRY STREET, Carson City, NV, 89703
Officers / Principals
| Title | Name | Address | Status |
|---|---|---|---|
| Mmember | TOTAL RENAL CARE, INC. | 2000 16TH STREET, JLDSECGOVFIN, Denver, CO | Active |
Total Medicaid Payments
$5,260,974
+50% vs specialty average
Patients Seen
27,498
Total Claims
277,054
$ Per Patient
$191
Specialty avg: $170
Specialty Rank
#11 of 52
Clinic/Center, End-Stage Renal Disease (ESRD) Treatment providers in Nevada
Peer Average
$3,517,617
Average total for Clinic/Center, End-Stage Renal Disease (ESRD) Treatment
Claims per Patient
10.1
Average visits / services per person
Payments by Year
How much Medicaid paid this provider each year. Large jumps can indicate changes in practice volume or billing patterns.
| Year | Total Paid | % of Max |
|---|---|---|
| 2018 | $646,475 | |
| 2019 | $846,976 | |
| 2020 | $782,992 | |
| 2021 | $682,229 | |
| 2022 | $880,612 | |
| 2023 | $903,988 | |
| 2024 | $517,704 |
Procedure Code Breakdown
The specific medical services this provider billed Medicaid for. Each HCPCS/CPT code represents a different type of visit, test, or treatment.
| HCPCS Code | Description | Claims | Paid | % of Total | Avg per Claim |
|---|---|---|---|---|---|
| 90999 | Dialysis or kidney treatment — other related procedure | 99,340 | $4,223,164 | 80.3% | $43 |
| 90945 | Peritoneal dialysis — cleaning blood through the belly (single treatment) | 23,411 | $1,000,829 | 19.0% | $43 |
| Q4081 | Injection, epoetin alfa, 100 units (for end-stage kidney disease on dialysis) | 65,620 | $22,672 | 0.4% | $0 |
| J1756 | Injection, iron sucrose, 1 mg | 16,413 | $8,357 | 0.2% | $1 |
| J0604 | Cinacalcet, oral, 1 mg, (for end-stage kidney disease on dialysis) | 400 | $5,645 | 0.1% | $14 |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc) | 2,011 | $152 | 0.0% | $0 |
| G0008 | Administration of influenza virus vaccine | 262 | $82 | 0.0% | $0 |
| 90661 | Vaccine or immunization | 17 | $74 | 0.0% | $4 |
| 90674 | Flu vaccine — standard injection | 71 | $0 | 0.0% | $0 |
| 82728 | Blood chemistry test (checking specific substances in your blood) | 4,246 | $0 | 0.0% | $0 |
| 85048 | Blood cell or clotting test | 5,943 | $0 | 0.0% | $0 |
| 83970 | Blood chemistry test (checking specific substances in your blood) | 4,896 | $0 | 0.0% | $0 |
| 83550 | Iron binding capacity test | 3,362 | $0 | 0.0% | $0 |
| 83540 | Iron blood test | 4,813 | $0 | 0.0% | $0 |
| 82306 | Vitamin D blood test | 908 | $0 | 0.0% | $0 |
| J0887 | Injection, epoetin beta, 1 microgram, (for end-stage kidney disease on dialysis) | 1,811 | $0 | 0.0% | $0 |
| J1270 | Injection, doxercalciferol, 1 mcg | 28,646 | $0 | 0.0% | $0 |
| 85041 | Blood cell or clotting test | 5,988 | $0 | 0.0% | $0 |
| 82108 | Blood chemistry test (checking specific substances in your blood) | 1,636 | $0 | 0.0% | $0 |
| 85045 | Blood cell or clotting test | 16 | $0 | 0.0% | $0 |
| A4657 | Syringe, with or without needle, each | 6,815 | $0 | 0.0% | $0 |
| 82746 | Blood chemistry test (checking specific substances in your blood) | 394 | $0 | 0.0% | $0 |
| 90662 | Vaccine or immunization | 35 | $0 | 0.0% | $0 |
About This Data
This data comes from the HHS Medicaid Provider Spending dataset (opendata.hhs.gov). It shows payments made through Nevada Medicaid from 2018–2024. High payments do not mean a provider is doing anything wrong — some specialties naturally cost more, and busy providers see more patients. But unusually high numbers compared to peers can be worth a closer look.